medigraphic.com
ISSN 0035-0052 (Print)

2007, Number 4

<< Back Next >>

Rev Mex Pediatr 2007; 74 (4)

Epidemiology of the hepatitis C virus in children

Álvarez-Hernández G, Sotelo-Cruz N, Cano-Rangel MA

Language: Spanish
References: 89
Page: 161-170
PDF size: 147.49 Kb.


ABSTRACT

Hepatitis C virus infection is a serious public health problem all over the world, and the health services are already facing numerous challenges due to the epidemiologic and financial burden caused by the disease. Chronic hepatitis C is one of the main causes of liver disease in adults. In children, hepatitis C infection is less frequent when compared to adults, but poses differences in its mode of transmission, epidemiologic features, clinical course, diagnosis criteria, and treatment. The aim of this paper is to give an overview about epidemiologic aspects of hepatitis C infection in children, detailing its magnitude, associated risk factors, as well as its epidemiologic challenges, and contribute to a better understanding about the problem in Mexico.


REFERENCES

  1. World Health Organization. Hepatitis C. Fact Sheet 164. Geneve, Switzerland. 2000. Recurso disponible online en: http://www.who.int/mediacentre/factsheets/fs164/en

  2. Desenclos JC. The challenge of hepatitis C surveillance. Eurosurveillance 2003; 8(5): 99-100

  3. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26: 521-26.

  4. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003; 36(1): 47-53.

  5. Davaalkham D, Ojima T, Nymadawa P et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006; 78: 466-72.

  6. Zhang M, Sun XD, Mark SD, Chen W, Wong L et al. Hepatitis C virus infection, Linxian, China. Emerg Inf Dis 2005; 11(1): 17-21.

  7. Lin DB, Tsai TP, Chen WK. Seroprevalence of hepatitis C virus infection and its association with natural infection of hepatitis B virus among preschool children in Taiwan. Eur J Epidemiol 2003; 18: 245-49.

  8. Jain A, Rana SS, Chakravarty P, Gupta NS et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 2003; 18: 695-97.

  9. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New Engl J Med 1999; 341: 556-62.

  10. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36: S30-S34.

  11. Strader DB, Wright T, Thomas DL, Seef LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39(4): 1147-71.

  12. Méndez-Sánchez N, Baptista-González H, Sánchez-Gómez RH et al. Prevalencia de hepatitis B y C en donadores de sangre de un hospital de tercer nivel de la ciudad de México. Salud Pública Mex 1999; 41: 475-78.

  13. Vivas-Arceo C, Aguilar-Benavides S, Trujillo JJ et al. Hepatitis C virus: prevalence and routes of infection among blood donors in West Mexico. Hepatol Res 2003; 25: 115-23.

  14. Rivera-López MR, Zavala-Méndez C, Arenas-Esqueda A. Prevalencia de seropositividad para VIH, hepatitis B y C en donadores de sangre. Gac Med Mex 2004; 140 (6): 657-660.

  15. Méndez-Sánchez N, Ponciano-Rodríguez G, Chávez-Tapia NC et al. Prevalence of hepatitis C infection in a population of asymptomatic people in a check-up unit in Mexico City. Digest Dis Sci 2005; 50(4): 733-37.

  16. Méndez-Sánchez N, Motola-Kuba D, Chávez-Tapia NC et al. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 2004; 42(9): 4321-22.

  17. Secretaría de Salud. Boletín Epidemiológico de la Dirección General de Epidemiología 2001-2005. México. Recurso online disponible en http://www.dgepi.salud.gob.mx/boletin/boletin.htm

  18. Jonas MM. Children with hepatitis C. Hepatology 2002; 36: S173-S178.

  19. El-Kamary SS, Serwint JR, Joffe A et al. Prevalence of hepatitis C virus infection in urban children. J Pediatr 2003; 143: 54-9.

  20. England K, Pembrey L, Tovo PA, Newell ML. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV infected mothers. Act Paediat 2005: 444-50.

  21. Jara P, Resti M, Hierro L, Giacchino R et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003; 36: 275-80.

  22. Jye-Bin L, Ding-Bang L, Shiuan-Chih C et al. Seroepidemiology of hepatitis A, B, C and E viruses infection among preschool children in Taiwan. J Med Virol 2006; 78: 18-23.

  23. Goldberg D, McIntyre PG, Smith R et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinkedanonymous testing. Br J Obstet Gynaecol 2001; 108: 365-70.

  24. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36: S106-S113.

  25. Silverman NS, Jenkin BK, Wu C et al. Hepatitis C virus in pregnancy: seroprevalence and risk factors for infection. Am J Obstet Gynecol 1993; 169: 583-87.

  26. Karim B, Alex G, Smith AL, Hardikar W. Hepatitis C infection in children: a Melbourne perspective. J Paediatr Child Health 2000; 36: 385-88.

  27. Laurent C, Henzel D, Mulanga-Kabeya C et al. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2001; 30: 872-77.

  28. Plunkett BA, Grobman WA. Routine hepatitis C virus screening in pregnancy: a cost-effective analysis. Am J Obstet Gynecol 2005; 192: 1153-61.

  29. Njouom R, Pasquier C, Ayouba A et al. Hepatitis C virus infection among pregnant women in Yaounde: prevalence, viremia, and genotypes. J Med Virol 2003; 69: 384-390.

  30. Gibb DM, Goodall RL, Dunn DT et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356: 904-7.

  31. Pembrey L, Tovo PA, Newell ML. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. Br J Obstet Gynaecol 2001; 108: 31-77.

  32. Santiago-Muñoz P, Roberts S, Sheffield J et al. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol 2005; 193: 1270-73.

  33. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289(18): 2413-17.

  34. Tahan V, Karaca C, Yildirim B et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005; 100: 821-24.

  35. Centers for Disease Prevention and Control. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47: 1-33.

  36. Choy Y, Gittens-Williams L, Apuzzio J et al. Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients. Infect Dis Obstet Gynecol 2003; 11: 191-98.

  37. Mesquita PE, Hernández-Granato CF, Castelo A. Risk factors associated with hepatitis C virus (HCV) infection among prostitutes and their clients in the city of Santos, Sao Paulo State, Brazil. J Med Virol 1997; 51: 338-43.

  38. Thomas DL, Zenilman JM, Alter HJ et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 partnerships. J Infect Dis 1995; 171: 768-75.

  39. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Sem Liver Dis 2000; 20(1): 1-16.

  40. Steininger C, Kundi M, Jatzko G et al. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 2003; 187: 345-51.

  41. Schackman BR, Oneda K, Goldie SJ. The cost-effectiveness of elective cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS 2004; 18: 1827-34.

  42. Arroyo-Carrera I, Martínez-Sapiña A, García-García J et al. Transmisión vertical del virus de la hepatitis C. Vox Paediatr 2003; 11(1): 7-11.

  43. Okamoto M, Nagata I, Murakami J et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000; 182: 1511-14.

  44. Mast EE, Hwang LY, Seto DSY et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-9.

  45. Zuccotti GV, Ribero ML, Giovannini L et al. Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr 1995; 127: 278-80.

  46. Zein NN. Vertical transmission of hepatitis C: to screen or not to screen? J Pediatr 1997; 130: 859-861 (Editorial).

  47. Lin HH, Kao JH, Hsu HY et al. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87: 244-8.

  48. Rumbo C. Hepatitis C: current approaches in pediatrics. Pediatr Transplantation 2005; 9: 662-65.

  49. Spencer JD, Latt N, Beeby PJ et al. Transmission of hepatitis C virus of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997; 4: 395-409.

  50. Healy CM, Cafferkey MT, Conroy A et al. Outcome of infants born to hepatitis C infected women. Ir J Med Sci 2001; 170: 103-176.

  51. Méndez-Sánchez N, Uribe M. Consenso Nacional sobre Hepatitis C. Conclusiones. Rev Invest Clin 2002; 54(6):559-568.

  52. Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33(5): 1341-42.

  53. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus: a meta-analysis. Int J Epidemiol 2003; 32: 727-734.

  54. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2006; 44: S28-S34.

  55. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138: 197-207.

  56. Delahooke TES. What is the nature of the problem? J Viral Hepat 2004; 11(S1): 5-11.

  57. Mazza C, Ravaggi A, Rodella A. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. J Med Virol 1998; 54: 12-19.

  58. Ruiz-Extremera A, Salmerón J, Torres C et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breastfeeding in transmission. Pediatr Infect Dis 2000; 19: 511-16.

  59. Ahktar S, Moatter T. Intra-household clustering of hepatitis C virus infection in Karachi, Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 535-39.

  60. Mastromatteo AM, Rapaccini GL, Pompili M et al. Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamilial spread. Hepatogastroenterology 2001; 48: 193-96.

  61. Ahktar S, Moatter T, Azam SI et al. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat 2002; 9: 309-14.

  62. Lins L, Almeida H, Vitvisk L et al. Detection of hepatitis C virus RNA in saliva is not related to oral health status or viral load. J Med Virol 2005; 77:216-20.

  63. Goncalves PL, Cunha CB, Busek SCU et al. Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies. Braz J Infect Dis 2005; 9(1): 28-34.

  64. García CD. Tratamiento de la hepatitis aguda por virus C. Rev Gastroenterol Mex 2002; 67: 61-66.

  65. Mondragón ZF, Cervantes BR. Hepatitis por virus C. Rev Enfer Infec Pediatr 2006; 75: 69-70.

  66. Hierro LL. Hepatitis C. El virus, métodos de diagnóstico, epidemiología, enfermedad autolimitada y crónica. An Pediatr 2003; 58: 489-91.

  67. National Institutes of Health (NIH). National Institutes of Health Consensus Development Conference Statement: management of hepatitis C, 2002. Hepatology 2002; 36: S3-S21.

  68. American Academy of Pediatrics. Committee on Infectious Diseases. Hepatitis C virus infection. Pediatr 1998; 101 (3): 481-85.

  69. Hierro-Lanillo I. Hepatitis C. Hepatitis crónica. Evolución y tratamiento. An Pediatr 2003; 58(5): 486-88.

  70. Vences-Aviles MA, González-Bravo F. Diagnóstico de la infección por el virus de la hepatitis C en donadores de sangre. Rev Mex Patol Clin 2005; 52: 6-12.

  71. Calzado AM, Gómez RM, Cordova C, Asensi BF. Hepatitis C en la infancia, revisión de 41 casos en el Hospital Infantil La Fé (Valencia España) atendidos en los últimos 15 años. Rev Enfer Infec Pediatr 2006; 76; 107-111.

  72. Marmesa A, Ozkan T, Ozeke T. The efficacy of antiviral therapy in children with chronic hepatitis C compared to its natural course. J Pediatr Gastroenterology Nutr 2004; 39: 170.

  73. Schwimmer JB, Balistreri W. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Sem Liver Dis 2000; 20(1): 37-46.

  74. Jhaveri R, Grant W, Kauf TL et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006; 148: 353-8.

  75. Wong JB, McQuillan GM, McHutchinson JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-69.

  76. Howie H, Hutchinson SJ. What lies ahead and can we afford it? J Viral Hepat 2004; 11 (S1): 28-33.

  77. Latt NC, Spencer JD, Beeby PJ et al. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 2000; 15: 175-8.

  78. Houghton M. The hepatitis C virus: a new paradigm for the identification and control of infectious disease. Nature Med 2000; 6(10): 1084-6.

  79. Mathei C, Shkedy Z, Denis B et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J Viral Hepat 2006; 13: 560-70.

  80. Haley RW, Fisher RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 662 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001; 80(2): 134-51.

  81. Haley RW, Fisher RP. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection. Arch Intern Med 2003; 163(9): 1095-8.

  82. Lee HW, Vasquez Y. Risk factors for hepatitis C on the Texas-Mexico Border. Am J Gastroenterol 2005; 100: 2180-5.

  83. Carithers RL, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Sem Liver Dis 2000; 20(2): 159-71.

  84. Alter MJ, Seeff LB, Bacon BR et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141: 715-7.

  85. Forns X, Costa J. HCV virological assessment. J Hepatol 2006; 44: S35-S39.

  86. Centers for Disease Prevention and Control. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep 2001; 50(RR13): 1-35.

  87. Strauss B, Bigham M. Hepatitis C surveillance - are we doing enough? British Columbia, 2001. Can Commun Dis Report 2001; 28(18): 149-56.

  88. Academia Mexicana de Pediatría. Hepatitis virales crónicas en niños y adolescentes. Bol Med Hosp Infant Mex 2001; 58(3): 198-204.

  89. Goldberg D, Anderson E. Who is at risk and how do we identify them? J Viral Hepat 2004; 11(S1): 12-18.




2020     |     www.medigraphic.com